ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Geriatric Medicine

Top Geriatric Medicine Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD WARREN MD

Geriatric Medicine

40,194

$2.23M

875
756 are 65+

16%
patients receiving schedule two controlled substances

Avg: 11%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

BRAD WHITNEY MD

Geriatric Medicine

32,723

$1.74M

767
677 are 65+

14%
patients receiving schedule two controlled substances

Avg: 11%

15%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $56

JAMES JEWELL MD

Geriatric Medicine

31,097

$1.72M

819
717 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

THOMAS CRUDEN M.D.

Geriatric Medicine

28,509

$1.71M

651
568 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

24%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $56

TAD VENN M.D.

Geriatric Medicine

27,175

$1.53M

553
503 are 65+

28%
patients receiving schedule two controlled substances

Avg: 11%

23%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

RICHARD SHERMAN DO

Geriatric Medicine

26,499

$1.47M

446
428 are 65+

16%
patients receiving schedule two controlled substances

Avg: 11%

15%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $56

MACDONALD DUBOSE M.D.

Geriatric Medicine

17,205

$916K

454
436 are 65+

7%
patients receiving schedule two controlled substances

Avg: 11%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $56

JOHN EMMEL MD

Geriatric Medicine

14,160

$698K

626
520 are 65+

13%
patients receiving schedule two controlled substances

Avg: 11%

16%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

RALPH D'AMORE MD

Geriatric Medicine

10,700

$606K

123
123 are 65+

10%
patients receiving schedule two controlled substances

Avg: 11%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $56

JOHN KLECKLEY M.D.

Geriatric Medicine

9,131

$555K

398
390 are 65+

3%
patients receiving schedule two controlled substances

Avg: 11%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

MELTON STUCKEY MD

Geriatric Medicine

6,451

$314K

298
224 are 65+

4%
patients receiving schedule two controlled substances

Avg: 11%

27%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

MARK MEILER MD

Geriatric Medicine

5,829

$359K

253
238 are 65+

6%
patients receiving schedule two controlled substances

Avg: 11%

24%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $56

MARION DAVIS M.D.

Geriatric Medicine

3,580

$536K

252
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 16%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$150
Average prescription price

Avg: $56

LAURIE THERIOT ROLEY M.D.

Geriatric Medicine

2,537

$137K

138
132 are 65+

17%
patients receiving schedule two controlled substances

Avg: 11%

9%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

STEVEN MCMURTRY M.D.

Geriatric Medicine

1,960

$66.3K

94
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

RAYMOND GRUBBS M.D.

Geriatric Medicine

1,804

$115K

218
200 are 65+

29%
patients receiving schedule two controlled substances

Avg: 11%

20%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

ROBERT HOUSTON MD

Geriatric Medicine

1,490

$58.3K

116
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

17%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

HIEP PHAM MD

Geriatric Medicine

1,174

$68.9K

92
89 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

23%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $56

CHARLES LAMAR M.D.

Geriatric Medicine

750

$16.9K

121
81 are 65+

9%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$23
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank